Clinical trial
A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
NCT03344861 is registered in ClinicalTrials.gov with Concordia Laboratories Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Prospective, Open-label, Non-randomized Single-arm Clinical Study of the Safety and Tissue Response to Photodynamic Therapy Using Porfimer Sodium for Injection as Treatment for Solid Lung Tumor Prior to Surgical Resection
- Lead sponsor
- Concordia Laboratories Inc.
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- August 14, 2017
- Completion date
- March 22, 2019
- Enrollment
- 10 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer, lung cancer metastatic